Goncalves-Pereira and Povoa meta-reviewed 57 reviews of pharmacokinetics of common beta-lactam antibiotics (piperacillin, meropenem, cefepime, ceftazidime, etc.) on patients in ICUs.
The results were troubling or at least confusing: studies reported wide variability in pharmacokinetics of beta-lactam antibiotics in critically ill patients, with volume of distribution and drug clearance varying more than 2-fold for the same drugs in similar patient populations.
The net result is that the time spent above minimum inhibitory concentration (T>MIC) — i.e., the expectation that therapeutic levels are present at usual dosing — was totally unpredictable. Tissue penetration was also compromised in patients with septic shock.
Their conclusion: Check levels often and dose drugs accordingly. My conclusion: get to know and love your friendly neighborhood ICU pharmacist.
Joao Goncalves-Pereira and Pedro Povoa. Antibiotics in critically ill patients – a systematic review of the pharmacokinetics of beta-Lactams. Critical Care 2011, 15:R206. FREE FULL TEXT
You may also like -
Can procalcitonin help guide therapy for suspected pneumonia & other infections? (Review, Chest)
Meropenem + moxifloxacin: no improvement over meropenem alone in severe sepsis (RCT, JAMA)
Pneumonia and Respiratory Infections: 2012 Update (Review, AJRCCM)
Cystic Fibrosis 2012 Update (Review, AJRCCM)
Systemic steroids for severe sepsis and septic shock (Review, AJRCCM)Liked this post? Get a weekly email update (no spam, ever), and explore our library of pulmonary and critical care guidelines, practice updates and review articles.